Table 3 Clinical characteristics of amyloidosis (N = 6) patients with VTD
From: Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis
Characteristics | |
|---|---|
Male/Female | 4/2 |
History of VTD | |
Personal | |
Yes | 1 |
No | 5 |
Family | |
No | 6 |
Serum M-Protein 1 | |
None | 3 |
Yes | 2 |
Unknown | 1 |
24-hour Urine Protein 1 | |
<0.15 gr | 3 |
>0.15 gr | 2 |
Unknown | 1 |
BMPC 2 | |
≤ 5% | 3 |
> 5% | 1 |
Unknown | 2 |
B 2 Microglobulin 1 | |
< 1.9 mg/L | 1 |
> 1.9 mg/L | 4 |
Unknown | 1 |
Serum albumin 1 | |
< 3.5 g/L | 3 |
3.5 – 5.0 g/L | 3 |
Immunoglobulin type | |
None | 4 |
IgG | 1 |
IgM | 1 |
None | 4 |
κ | 2 |
WBC count | |
4 – 11 × 106/L | 6 |
Platelet count | |
150 – 400 × 106/L | 6 |